[
  {
    "ts": null,
    "headline": "Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.",
    "summary": "Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque AnalysisMOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. Aetna is the fourth major national commercial ins",
    "url": "https://finnhub.io/api/news?id=32797df2175b14695226f3550a6f496b2f4169e162dd1a88b236c1a6652ebbf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767704400,
      "headline": "Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.",
      "id": 138000228,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque AnalysisMOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. Aetna is the fourth major national commercial ins",
      "url": "https://finnhub.io/api/news?id=32797df2175b14695226f3550a6f496b2f4169e162dd1a88b236c1a6652ebbf8"
    }
  },
  {
    "ts": null,
    "headline": "Is Humana (HUM) Offering Value After DCF And P/E Suggest Upside Potential",
    "summary": "If you are wondering whether Humana's current share price still reflects good value, it helps to step back and look at what the recent returns and fundamentals are actually telling you. Humana's stock last closed at US$275.80, with returns of 6.5% over the past week, 7.0% over the past month, 4.3% year to date, 4.7% over the past year, a 40.8% decline over three years, and a 31.7% decline over five years. Taken together, these figures give a mixed picture of recent momentum and longer term...",
    "url": "https://finnhub.io/api/news?id=676966fe4ebd645e8e6d7daa6e48199f77118688e8d77af06f9d7b1d18305a34",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767697873,
      "headline": "Is Humana (HUM) Offering Value After DCF And P/E Suggest Upside Potential",
      "id": 137999494,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "If you are wondering whether Humana's current share price still reflects good value, it helps to step back and look at what the recent returns and fundamentals are actually telling you. Humana's stock last closed at US$275.80, with returns of 6.5% over the past week, 7.0% over the past month, 4.3% year to date, 4.7% over the past year, a 40.8% decline over three years, and a 31.7% decline over five years. Taken together, these figures give a mixed picture of recent momentum and longer term...",
      "url": "https://finnhub.io/api/news?id=676966fe4ebd645e8e6d7daa6e48199f77118688e8d77af06f9d7b1d18305a34"
    }
  }
]